Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Adaptive randomization of veliparib-carboplatin treatment in breast cancer
the I-SPY 2 Investigators
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
478
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adaptive randomization of veliparib-carboplatin treatment in breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Genetics
50%
Poly ADP Ribose Polymerase
50%
Magnetism
50%
Tumor Volume
50%
Hormone Receptor
50%
Keyphrases
Veliparib
100%
Tumor Volume Change
12%
Control Therapy
12%
Medicine and Dentistry
Veliparib
100%
Pharmacology, Toxicology and Pharmaceutical Science
Veliparib
100%